Literature DB >> 1526986

Ceramide-mediated biology. Determination of structural and stereospecific requirements through the use of N-acyl-phenylaminoalcohol analogs.

A Bielawska1, C M Linardic, Y A Hannun.   

Abstract

Ceramide is a postulated intracellular modulator of cell growth and differentiation (Okazaki, T., Bielawska, A., Bell, R.M., and Hannun, Y. A. (1990) J. Biol. Chem. 265, 15823-15831). In order to determine the structural and stereospecific requirements for ceramide effects on HL-60 cells, N-acyl-phenylaminoalcohol analogs were synthesized and evaluated for their ability to mimic the effects of ceramide on cell proliferation and differentiation. These compounds share with ceramide a similar polar headgroup that allows the investigation of the roles of the primary and secondary hydroxyls, the hydrophobicity of the molecule, and stereospecificity. N-Myristoyl derivatives of phenylamino alcohols showed optimal activity over other chain length analogs and were able to mimic the effects of C2-ceramide on cell growth and differentiation. Neither the primary nor the secondary alcohol was necessary for activity, but the amide-linked acyl chain was required. Stereospecificity of action was demonstrated with an enantiomeric pair: D-erythro-N-myristoyl-2-amino-1-phenyl-1-propanol (C14-D-e-APP-1) and L-erythro-N-myristoyl-2-amino-1-phenyl-1-propanol (C14-L-e-APP-1). The D stereoisomer was as effective as C2-ceramide in inhibiting HL-60 cell growth and in inducing cell differentiation, whereas the L enantiomer lacked activity in both assays. These results suggest stereospecific action of ceramide and strongly support a physiologic role for ceramide as an intracellular mediator with primary roles in regulation of cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids.

Authors:  Alicja Bielawska; Jacek Bielawski; Zdzislaw M Szulc; Nalini Mayroo; Xiang Liu; AiPing Bai; Saeed Elojeimy; Barbara Rembiesa; Jason Pierce; James S Norris; Yusuf A Hannun
Journal:  Bioorg Med Chem       Date:  2007-08-24       Impact factor: 3.641

2.  Synthesis and bioevaluation of omega-N-amino analogs of B13.

Authors:  Aiping Bai; Zdzislaw M Szulc; Jacek Bielawski; Nalini Mayroo; Xiang Liu; James Norris; Yusuf A Hannun; Alicja Bielawska
Journal:  Bioorg Med Chem       Date:  2009-01-31       Impact factor: 3.641

3.  Discovery and evaluation of inhibitors of human ceramidase.

Authors:  Jeremiah M Draper; Zuping Xia; Ryan A Smith; Yan Zhuang; Wenxue Wang; Charles D Smith
Journal:  Mol Cancer Ther       Date:  2011-09-01       Impact factor: 6.261

4.  p53-dependent ceramide response to genotoxic stress.

Authors:  G S Dbaibo; M Y Pushkareva; R A Rachid; N Alter; M J Smyth; L M Obeid; Y A Hannun
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

5.  Targeting (cellular) lysosomal acid ceramidase by B13: design, synthesis and evaluation of novel DMG-B13 ester prodrugs.

Authors:  Aiping Bai; Zdzislaw M Szulc; Jacek Bielawski; Jason S Pierce; Barbara Rembiesa; Silva Terzieva; Cungui Mao; Ruijuan Xu; Bill Wu; Christopher J Clarke; Benjamin Newcomb; Xiang Liu; James Norris; Yusuf A Hannun; Alicja Bielawska
Journal:  Bioorg Med Chem       Date:  2014-10-22       Impact factor: 3.641

Review 6.  Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Authors:  Christina Voelkel-Johnson; James S Norris; Shai White-Gilbertson
Journal:  Adv Cancer Res       Date:  2018-06-20       Impact factor: 6.242

7.  Potent inhibition of Acid ceramidase by novel B-13 analogues.

Authors:  Denny Proksch; Jan Jasper Klein; Christoph Arenz
Journal:  J Lipids       Date:  2010-12-09

8.  Keratinocyte differentiation is induced by cell-permeant ceramides and its proliferation is promoted by sphingosine.

Authors:  H Wakita; Y Tokura; H Yagi; K Nishimura; F Furukawa; M Takigawa
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

9.  Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites.

Authors:  Aiping Bai; Alicja Bielawska; Mehrdad Rahmaniyan; Jacqueline M Kraveka; Jacek Bielawski; Yusuf A Hannun
Journal:  Bioorg Med Chem       Date:  2018-11-10       Impact factor: 3.641

Review 10.  A review of ceramide analogs as potential anticancer agents.

Authors:  Jiawang Liu; Barbara S Beckman; Maryam Foroozesh
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.